-
Signature
-
/s/ Jillian Forusz, as attorney-in-fact
-
Stock symbol
-
ADBE
-
Transactions as of
-
Jul 15, 2024
-
Transactions value $
-
-$168,980
-
Form type
-
4
-
Date filed
-
7/17/2024, 06:37 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ADBE |
Common Stock |
Options Exercise |
$0 |
+190 |
+6.79% |
$0.00 |
2.99K |
Jul 15, 2024 |
Direct |
F1 |
| transaction |
ADBE |
Common Stock |
Tax liability |
-$53.2K |
-94 |
-3.15% |
$565.71 |
2.89K |
Jul 15, 2024 |
Direct |
F2 |
| transaction |
ADBE |
Common Stock |
Options Exercise |
$0 |
+109 |
+3.77% |
$0.00 |
3K |
Jul 15, 2024 |
Direct |
|
| transaction |
ADBE |
Common Stock |
Tax liability |
-$30.5K |
-54 |
-1.8% |
$565.71 |
2.95K |
Jul 15, 2024 |
Direct |
F2 |
| transaction |
ADBE |
Common Stock |
Sale |
-$85.3K |
-151 |
-5.12% |
$564.60 |
2.8K |
Jul 16, 2024 |
Direct |
F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ADBE |
Restricted Stock Units |
Options Exercise |
$0 |
-190 |
-9.08% |
$0.00 |
1.9K |
Jul 15, 2024 |
Common Stock |
190 |
$0.00 |
Direct |
F4 |
| transaction |
ADBE |
Restricted Stock Units |
Options Exercise |
$0 |
-109 |
-6.65% |
$0.00 |
1.53K |
Jul 15, 2024 |
Common Stock |
109 |
$0.00 |
Direct |
F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: